Growth Metrics

Phathom Pharmaceuticals (PHAT) Times Interest Earned: 2022-2025

Historic Times Interest Earned for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to -$0.95.

  • Phathom Pharmaceuticals' Times Interest Earned rose 75.25% to -$0.95 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.04, marking a year-over-year increase of 29.91%. This contributed to the annual value of -$3.85 for FY2024, which is 3.35% up from last year.
  • Latest data reveals that Phathom Pharmaceuticals reported Times Interest Earned of -$0.95 as of Q3 2025, which was up 72.29% from -$3.42 recorded in Q2 2025.
  • In the past 5 years, Phathom Pharmaceuticals' Times Interest Earned ranged from a high of -$0.95 in Q3 2025 and a low of -$13.74 during Q1 2022.
  • Its 3-year average for Times Interest Earned is -$3.60, with a median of -$3.53 in 2023.
  • Per our database at Business Quant, Phathom Pharmaceuticals' Times Interest Earned spiked by 76.25% in 2023 and then plummeted by 31.98% in 2024.
  • Over the past 4 years, Phathom Pharmaceuticals' Times Interest Earned (Quarterly) stood at -$4.86 in 2022, then decreased by 10.41% to -$5.36 in 2023, then skyrocketed by 40.41% to -$3.20 in 2024, then surged by 75.25% to -$0.95 in 2025.
  • Its last three reported values are -$0.95 in Q3 2025, -$3.42 for Q2 2025, and -$4.36 during Q1 2025.